MENU
+Compare
ENTA
Stock ticker: NASDAQ
AS OF
Jan 31, 01:31 PM (EDT)
Price
$5.29
Change
+$0.15 (+2.92%)
Capitalization
106.24M

ENTA Enanta Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of drugs and other pharmaceuticals products

Industry Biotechnology
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ENTA with price predictions
Jan 29, 2025

Momentum Indicator for ENTA turns positive, indicating new upward trend

ENTA saw its Momentum Indicator move above the 0 level on January 23, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ENTA's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ENTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where ENTA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ENTA entered a downward trend on January 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ENTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.851) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). ENTA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (1.608) is also within normal values, averaging (276.027).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ENTA is expected to report earnings to fall 6.62% to -126 cents per share on February 05

Enanta Pharmaceuticals ENTA Stock Earnings Reports
Q4'24
Est.
$-1.27
Q3'24
Missed
by $0.20
Q2'24
Beat
by $0.36
Q1'24
Missed
by $0.13
Q4'23
Missed
by $1.75
The last earnings report on November 25 showed earnings per share of -136 cents, missing the estimate of -115 cents. With 17.99K shares outstanding, the current market capitalization sits at 106.24M.
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STRNY31.440.69
+2.24%
Severn Trent PLC
MSADY21.160.35
+1.68%
MS&AD Insurance Group Holdings, Inc.
CMPGY34.380.19
+0.56%
Compass Group Plc
CBTTF0.05N/A
-2.53%
Cathedra Bitcoin Inc
CYDY0.19-0.02
-8.64%
CytoDyn Inc.

ENTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with CLRB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+3.21%
CLRB - ENTA
42%
Loosely correlated
+2.68%
AURA - ENTA
38%
Loosely correlated
+0.13%
NTLA - ENTA
37%
Loosely correlated
+3.85%
VRDN - ENTA
37%
Loosely correlated
+3.35%
STOK - ENTA
37%
Loosely correlated
+4.57%
More